对于非透析患者的风病治疗
Atsushi Ohkubo1, Takatoshi Sakurasawa1, Yuki Hoshikawa1
1Medical Engineering Center, Institute of Science Tokyo Hospital, Tokyo, Japan.
概括
在非透析患者中,慢性四肢缺血的rheocarna治疗显示出的愈合,尽管有些需要皮肤移植. 本研究详细介绍了该患者群的治疗条件和有效性.
科学领域:
- 血管医学 血管医学
- 再生医学是一种再生医学.
背景情况:
- 雷奥卡纳是慢性肢体威胁性缺血的新兴疗法.
- 之前的研究集中在透析患者身上,在了解其在非透析患者中的使用方面存在差距.
研究的目的:
- 研究Rheocarna在非透析患者的治疗条件和疗效,这些患者患有慢性肢体威胁性缺血症.
主要方法:
- 一项针对四名接受Rheocarna治疗的非透析患者的案例研究.
- 治疗参数的文件,包括持续时间,血液流速和处理的血液体积.
主要成果:
- 所有患者都观察到完全愈合.
- 两名患者需要随后的皮肤移植手术.
- 治疗时间为90-120分钟,血液流量为50-80毫升/分钟,处理量约为循环血液体积的1.0倍.
- 低密度脂蛋白和纤维蛋白去除率很低 (10%-15%).
结论:
- 雷奥卡纳可以有效地促进非透析的慢性肢体威胁性缺血症患者的愈.
- 该研究提供了对这一群体最佳治疗参数的初步数据.
- 这是第一个详细介绍Rheocarna在非透析患者中的应用和结果的报告.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
321
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
321
Dialysis
231
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
231


